Abstract

BackgroundPt reported outcomes (PROs) play a role in disease evaluation, therapeutic assessment and care of RA pts. The Pt Reported Outcomes Measurement Information System (PROMIS [P]) questionnaires developed by NIH...

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
THU0672 Real world evidence comparing the patient reported outcomes measurement information system to the cdai in rheumatoid arthritis patients
...
Annals of the Rheumatic Diseases | VOL. 76
, et. al. ...
01 Jun 2017
Patient Disease Trajectories in Rheumatoid Arthritis Patients Treated with Baricitinib 4-mg in FourPhase 3 Clinical Studies.
Peter C Taylor ... Andrea Rubbert-Roth
Rheumatology and therapy | VOL. 10
Peter C Taylor, et. al.Peter C Taylor ... Andrea Rubbert-Roth
20 Jan 2023
OP0178 Impact of Anti-Cyclic Citrullinated Peptide and Rheumatoid Factor Status on Response To Abatacept Therapy: Findings from A US Observational Cohort
L.R Harrold ... J.M Kremer
Annals of the Rheumatic Diseases | VOL. 75
L.R Harrold, et. al.L.R Harrold ... J.M Kremer
01 Jun 2016
AB0320 Patient-assessed disease activity score (PDAS) corresponds to standard disease statuses and response criteria defined by disease activity score 28 (DAS28) and clinical disease activity index (CDAI)
M.-H.A Leung ... D Farewell
Annals of the Rheumatic Diseases | VOL. 71
M.-H.A Leung, et. al.M.-H.A Leung ... D Farewell
01 Jun 2013
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
Assessing the performance of AI chatbots in answering patients’ common questions about low back pain
Simone P S Scaff ... Bruno T Saragiotto
Annals of the Rheumatic Diseases | VOL. -
Simone P S Scaff, et. al.Simone P S Scaff ... Bruno T Saragiotto
18 Sep 2024
Human hypofunctional NCF1 variants promote pulmonary fibrosis in the bleomycin-induced mouse model and patients with systemic sclerosis via expansion of SPP1+ monocytes-derived macrophages
Xinran Yuan ... Betty P Tsao
Annals of the Rheumatic Diseases | VOL. -
Xinran Yuan, et. al.Xinran Yuan ... Betty P Tsao
18 Sep 2024
Lupus and inflammatory bowel disease share a common set of microbiome features distinct from other autoimmune disorders
Hao Zhou ... Ilana Brito
Annals of the Rheumatic Diseases | VOL. -
Hao Zhou, et. al.Hao Zhou ... Ilana Brito
18 Sep 2024
Is a 1-year course of methotrexate in patients with arthralgia at-risk for rheumatoid arthritis cost-effective? A cost-effectiveness analysis of the randomised, placebo-controlled TREAT EARLIER trial
Elise Van Mulligen ... Annette Van Der Helm-Van Mil
Annals of the Rheumatic Diseases | VOL. -
Elise Van Mulligen, et. al.Elise Van Mulligen ... Annette Van Der Helm-Van Mil
18 Sep 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.